A susceptibility locus for Parkinson's disease maps to chromosome 2p13
Thomas Gasser(Hertie Institute for Clinical Brain Research), Rolf D. Horstmann(Bernhard Nocht Institute for Tropical Medicine), Bertram Müller‐Myhsok(Max Planck Institute of Psychiatry), Vincenzo Bonifati(University Medical Center), Benjámin Bereznai(Ludwig-Maximilians-Universität München), Edito Fabrizio(Ludwig-Maximilians-Universität München), P. Vieregge(Ludwig-Maximilians-Universität München), Ralph Oehlmann(Ludwig-Maximilians-Universität München), Donald B. Calne(University of British Columbia), Zbigniew K. Wszołek(WinnMed)
Cited by 459
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k